
Academic Journal
Q1Retrovirology
About Retrovirology
Retrovirology is a scholarly journal published by BioMed Central Ltd. SCImago 2025 lists it in Q1, with an SJR of 1.355 and H-index of 104.
Coverage: 2004-2026. Research categories: Infectious Diseases (Q1); Virology (Q1).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-17. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
HIV Research and Treatment; HIV/AIDS drug development and treatment; T-cell and Retrovirus Studies; Immune Cell Function and Interaction; HIV/AIDS Research and Interventions; Animal Disease Management and Epidemiology.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Divergent proviral load trajectories and clonal dynamics of HTLV-1-infected cells during antirheumatic therapy in rheumatoid arthritis
Kunihiko Umekita, Masatoshi Kimura, Masayuki Murai, Chihiro Iwao et al.
2026-09-12 · DOI: 10.1186/s12977-026-00686-5Clonal dynamics of HTLV-1–infected cells under immunosuppression stratify ATL risk and reveal restoration of Tax-specific immune surveillance
Yumi Ashikawa, Makoto Nakashima, Masumichi Saito, Naomi Nojiri et al.
2026-08-25 · DOI: 10.1186/s12977-026-00685-6HTLV infection among pregnant women attending a viral hepatitis referral center in Rio de Janeiro, Brazil
Vinicius M. Mello, Giovana S. N. Guimaraes, Kaio C. P. Ferreira, Paulo S. F. Sousa et al.
2026-08-22 · DOI: 10.1186/s12977-026-00681-wAn ex vivo gut mucosal explant assay to compare HIV tissue susceptibility shows increased HIV susceptibility with methamphetamine exposure
Julie Elliott, Nicholas E. Webb, Paola Ruiz, Grace D. Cho et al.
2026-08-18 · DOI: 10.1186/s12977-026-00684-7Distinct amino acid signatures and neutralization sensitivity of plasma- and CSF-derived HIV-1 subtype C clones
Silondoloze Mtanjana, Nombali Gumede, Nelisiwe Zikhali, Ntokozo Ntshangase et al.
2026-08-02 · DOI: 10.1186/s12977-026-00683-8Virus-informed targeting of HIV reservoirs: Rev-dependent HIV Immunotherapy (RHIT)
Yuntao Wu
2026-07-23 · DOI: 10.1186/s12977-026-00682-9Genetic and transcriptomic signatures of host control in HIV-1 infection
Sergey Oreshkov, Christian W. Thorball, Jenny Meylan, Maude Muriset et al.
2026-06-16 · DOI: 10.1186/s12977-026-00679-4Metabolic reprogramming of CD4⁺ T cells by Zaprinast induces HIV-1 latency reversal ex vivo
V. De Masson d’Autume, V. LeDouce, A. Dutilleul, S. O’Reilly et al.
2026-06-13 · DOI: 10.1186/s12977-026-00680-xNon-integrase mechanisms for dolutegravir resistance
Alan N. Engelman
2026-06-05 · DOI: 10.1186/s12977-026-00678-5Robin A. Weiss FRS (1940-2026)
Ariberto Fassati
2026-04-28 · DOI: 10.1186/s12977-026-00677-6Functional dissection of the prototype foamy virus glycoprotein heparan sulfate binding site
Max Büttrich, Nicole Stanke-Scheffler, Thomas Calcraft, Peter B. Rosenthal et al.
2026-03-21 · DOI: 10.1186/s12977-026-00676-7The KT Jeang retrovirology prize 2025: Carine Van Lint
Carine Van Lint
2026-02-26 · DOI: 10.1186/s12977-025-00673-2Versatile HIV Rev-dependent reporter cell system for stringent and sensitive quantification of viral reservoirs, neutralizing antibodies, and restriction factors
Mark Spear, Joseph Choi, Brian Hetrick, JeongHwan Lee et al.
2026-02-11 · DOI: 10.1186/s12977-026-00675-8Human betaretrovirus (HBRV), homologous to mouse mammary tumor virus (MMTV), and human breast cancer: a significant epidemiological association
Fateme Saeedi-Moghaddam, Nazila Saffarian, Sayed-Hamidreza Mozhgani
2026-02-09 · DOI: 10.1186/s12977-025-00674-1Investigation of the expression level of human endogenous retrovirus E env transcript in cervical cancer
Shaghayegh Jahanshahi, Rahim Soleimani-Jelodar, Somayeh Jalilvand, Zabihollah Shoja et al.
2026-02-02 · DOI: 10.1186/s12977-025-00672-3Strand-specific detection of cell-associated sense and antisense HIV-1 RNAs in splenocytes and PBMC from PLWH
Laetitia Waast, Aurélien Geronimi, Adeline Mélard, Suzanne Figueiredo et al.
2025-12-24 · DOI: 10.1186/s12977-025-00670-5Transcriptome mining reveals diversity and evolution of circulating and endogenous amphibian retroviruses
Emma F. Harding, Banjo Webster, Tanu Sridhar, Lewis K. Mercer et al.
2025-12-10 · DOI: 10.1186/s12977-025-00669-yIntra-pol proviral open region of HTLV-1 controls the transcription from both long terminal repeats
Miyu Sonoda, Azusa Tanaka, Xueda Chen, Wenyi Zhang et al.
2025-12-08 · DOI: 10.1186/s12977-025-00671-4Unveiling the dynamics: understanding the current scenario and drivers of HIV epidemiology in Pakistan
Akmal Zubair, Muhammad Ali, Safa Wdidi, Adel Qlayel Alkhedaide et al.
2025-09-19 · DOI: 10.1186/s12977-025-00668-zt-RNA mediates provirus deletion in HIV-infected cells
Corrado Gurgo, Genoveffa Franchini
2025-07-01 · DOI: 10.1186/s12977-025-00667-0Reviews
Community Reviews
Version History
September 25, 2026 at 7:32 am
September 25, 2026